Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,933.00
Ask: 1,935.00
Change: 17.00 (0.89%)
Spread: 2.00 (0.103%)
Open: 1,922.00
High: 1,936.00
Low: 1,904.00
Prev. Close: 1,913.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: SocGen Downgrades Sage Group To Sell From Hold

Fri, 13th Mar 2015 09:39

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN CUTS SAGE GROUP TO 'SELL' ('HOLD') - TARGET 435 (430) PENCE
----------
S&P CAPITAL IQ RAISES MORRISON PRICE TARGET TO 185 (155) PENCE - 'SELL'
----------
CITIGROUP RAISES MORRISON PRICE TARGET TO 235 (190) PENCE - 'BUY'
---------
BERENBERG RAISES BT GROUP PRICE TARGET TO 570 (475) PENCE - 'BUY'
---------
GOLDMAN RAISES ADMIRAL GROUP PRICE TARGET TO 1435 (1425) PENCE - 'NEUTRAL'
---------
GOLDMAN RAISES ITV PRICE TARGET TO 294 (284) PENCE - 'CONVICTION BUY LIST'
---------
HSBC RAISES ITV PRICE TARGET TO 270 (255) PENCE - 'NEUTRAL'
---------
UBS RAISES WHITBREAD TO 'NEUTRAL' ('SELL') - TARGET 5400 (4700) PENCE
---------
MORGAN STANLEY RAISES ROLLS-ROYCE PRICE TARGET TO 1170 (1040) PENCE
---------
MORGAN STANLEY CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
---------
BARCLAYS RAISES BHP BILLITON PRICE TARGET TO 1600 (1500) PENCE - 'OVERWEIGHT'
---------
CREDIT SUISSE CUTS DIAGEO PRICE TARGET TO 1700 (1850) PENCE - 'UNDERPERFORM'
---------
BARCLAYS CUTS DIAGEO PRICE TARGET TO 2030 (2050) PENCE - 'OVERWEIGHT'
---------
BARCLAYS RAISES WOLSELEY PRICE TARGET TO 4700 (4000) PENCE - 'OVERWEIGHT'
---------
CREDIT SUISSE RAISES PRUDENTIAL PRICE TARGET TO 1900 (1750) PENCE - 'OUTPERFORM'
---------
Bernstein Raises WPP Price Target To 1,950p From 1,500p, Maintains Outperform
---------
JPMORGAN RAISES STANDARD LIFE PRICE TARGET TO 483 (460) PENCE - 'OVERWEIGHT'
---------
JPMORGAN CUTS SMITHS GROUP PRICE TARGET TO 1323 (1430) PENCE - 'OVERWEIGHT'
---------
HSBC RAISES FRESNILLO PRICE TARGET TO 1100 (1050) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
GOLDMAN CUTS HIKMA PHARMACEUTICALS TARGET TO 2210 (2410) PENCE - 'NEUTRAL'
---------
GOLDMAN RAISES VEDANTA PRICE TARGET TO 500 (490) PENCE - 'NEUTRAL'
---------
UBS RAISES VESUVIUS PRICE TARGET TO 610 (560) PENCE - 'BUY'
---------
UBS CUTS HOME RETAIL PRICE TARGET TO 235 (250) PENCE - 'BUY'
---------
CITIGROUP CUTS HOME RETAIL PRICE TARGET TO 195 (200) PENCE - 'NEUTRAL'
---------
NOMURA CUTS HOME RETAIL PRICE TARGET TO 210 (245) PENCE - 'BUY'
---------
UBS RAISES LAIRD PRICE TARGET TO 365 (355) PENCE - 'BUY'
---------
BARCLAYS CUTS BRITVIC PRICE TARGET TO 775 (800) PENCE - 'OVERWEIGHT'
---------
CITIGROUP RAISES SIG PRICE TARGET TO 220 (205) PENCE - 'BUY'
---------
CITIGROUP RAISES BETFAIR PRICE TARGET TO 2150 (1700) PENCE - 'NEUTRAL'
---------
Nomura Initiates TSB Banking At Buy, Price Target 360p
---------
CANACCORD RAISES TSB TO 'HOLD' ('SELL') - TARGET 340 (235) PENCE
---------
JPMORGAN RAISES CINEWORLD PRICE TARGET TO 500 (450) PENCE - 'OVERWEIGHT'
---------
MORGAN STANLEY RAISES POUNDLAND GROUP TARGET TO 280 (245) PENCE - 'UNDERWEIGHT'
---------
N+1 Singer Cuts JD Wetherspoon To Sell From Hold, Price Target Place Under Review From 776p
---------
Numis Cuts JD Wetherspoon Price Target To 800p From 850p, Reiterates Hold
---------
JEFFERIES CUTS SOCO INTERNATIONAL PRICE TARGET TO 180 (240) PENCE - 'HOLD'
---------
PANMURE RAISES JLT GROUP PRICE TARGET TO 1150 (990) PENCE - 'BUY'
---------
Investec Raises HellermannTyton Price Target To 335p From 305p, Reiterates Hold
---------
HSBC RAISES PAGE GROUP PRICE TARGET TO 632 (461) PENCE - 'OVERWEIGHT'
----------
MAIN MARKET AND AIM
----------
SOCGEN RAISES ASOS PRICE TARGET TO 4666 (4450) PENCE - 'BUY'
---------
JPMORGAN RAISES ASOS PRICE TARGET TO 3600 (3100) PENCE - 'OVERWEIGHT'
---------
CITIGROUP CUTS FENNER PRICE TARGET TO 230 (260) PENCE - 'BUY'
---------
JPMORGAN CUTS FENNER PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
---------
JEFFERIES CUTS FENNER PRICE TARGET TO 225 (260) PENCE - 'BUY'
---------
JPMORGAN CUTS STOCK SPIRITS PRICE TARGET TO 250 (270) PENCE - 'OVERWEIGHT'
---------
JEFFERIES RAISES LSL PROPERTY SERVICES TO 'BUY' ('HOLD') - TARGET 375 (290) PENCE
---------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.